enVVeno receives ‘unfavorable’ appeal decision from FDA for VenoValve device
enVVeno Medical has announced that it has received an "unfavorable" decision from the US Food & Drug Administration (FDA) in response to its supervisory...
New Medicare analysis shows increased thrombectomy use in venous disease
A new review of Medicare data shows a marked increase for both arterial and venous thrombectomy claims for venous thromboembolic disease filed between 2017–2022.
Researchers...
PE thrombectomy: ENGULF pivotal study meets safety and efficacy endpoints
Full results from the ENGULF pivotal study of the Hēlo thrombectomy system (Endovascular Engineering) in acute intermediate risk pulmonary embolism (PE) patients demonstrated a...
CAVT with anticoagulation significantly improves functional outcomes in PE patients, RCT shows
Mechanical thrombectomy by means of computer-assisted vacuum thrombectomy (CAVT) using the 16Fr Lightning Flash system (Penumbra) along with anticoagulation for acute-to-intermediate pulmonary embolism (PE)...
